Ucci-Hn-19-02- Determining Hbd-3 As A Valid Biomarker In Head And Neck Cancer.
Posted Date: Oct 15, 2019
- Investigator: Alice Tang
- Specialties: Cancer, Head and Neck Cancer, Oncology
- Type of Study: Observational/Survey
The goal of this study is to replicate the beta defensin index's ability to distinguish oral squamous cell carcinoma from non-cancerous lesions
Criteria:
To Be Eligible: 18 Years Or Older, Diagnosis Of Head And Neck Cancer, Any Condition Pi Finds To Be Confounding With Their Ability To Properly Participate In The Study
Keywords:
Head And Neck Cancer, Hnc, Oncology
For More Information:
Uccc Cancer Center
513-584-7698
cancer@uchealth.com